|
|
Volumn 9 Suppl 3, Issue , 2009, Pages
|
|
T-cell prolymphocytic leukemia.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALEMTUZUMAB;
ANTINEOPLASTIC AGENT;
CANCER ANTIBODY;
MONOCLONAL ANTIBODY;
PENTOSTATIN;
AGED;
ALLOTRANSPLANTATION;
FEMALE;
GENE EXPRESSION REGULATION;
HUMAN;
IMMUNOPHENOTYPING;
MALE;
METHODOLOGY;
MIDDLE AGED;
ONCOLOGY;
PROLYMPHOCYTIC LEUKEMIA;
REVIEW;
STEM CELL TRANSPLANTATION;
TREATMENT OUTCOME;
AGED;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, NEOPLASM;
ANTINEOPLASTIC AGENTS;
FEMALE;
GENE EXPRESSION REGULATION, LEUKEMIC;
HUMANS;
IMMUNOPHENOTYPING;
LEUKEMIA, PROLYMPHOCYTIC, T-CELL;
MALE;
MEDICAL ONCOLOGY;
MIDDLE AGED;
PENTOSTATIN;
STEM CELL TRANSPLANTATION;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
|
EID: 74049085471
PISSN: None
EISSN: 19380712
Source Type: Journal
DOI: 10.3816/clm.2009.s.018 Document Type: Review |
|
Times cited : (27)
|
|
References (38)
|
